CB Issuance Details Amended, Dilution Risk Up
리가켐바이오
141080
Signal Score
Historical Avg Return (5d)
+0.00%
Data Coverage
100%n=2571
Risk-adjusted indicator based on 2571 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEGATIVE
Key Numbers
- • Total CB Issuance: 170B KRW
- • Amended Conversion Price: 121,400 KRW/Share (down from 149,300 KRW/Share)
- • Amended Convertible Shares: 1,400,329 Shares (up from 1,138,647 Shares)
- • Amended Dilution Rate: 3.78% (up from 3.08%)
- • Lowest Adjustment Price: 97,200 KRW
AI Analysis Summary
LigaChem Biosciences Inc. has amended its Material Fact Report regarding the issuance of convertible bonds (CBs). The total CB issuance remains 170B KRW, but the conversion price has been adjusted downwards from 149,300 KRW/Share to 121,400 KRW/Share. This change increases the number of convertible shares from 1,138,647 to 1,400,329, leading to a higher potential dilution rate for existing shareholders, now at 3.78% (previously 3.08%). The lowest adjustment price for the conversion is set at 97,200 KRW. This amendment indicates increased potential dilution, which is generally negative for existing shareholders.
How This Event Is Evaluated
Capital Raise Evaluation
Capital raise events are evaluated by estimating dilution pressure, funding purpose, pricing terms, and impact on existing shareholders.
AI is used to interpret disclosures and extract structured data.
Signal scores are generated using event-specific methodologies and quantitative models.
- Potential dilution rate
- Issuance or conversion price
- Funding purpose
- Shareholder value impact
Track Korean Market Signals — Free
Sign up free to access live disclosures, AI analysis, and event filters.
Public Beta · No credit card required
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.